Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 17.48
+0.04 (0.23%)
At close: Mar 2, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 811.62 million as of March 2, 2026. Its market cap has decreased by -1.46% in one year.
Market Cap
811.62M
Enterprise Value
332.26M
Revenue
57.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.48
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 811.62M, a decrease of -46.51%. That is a compound annual growth rate of -30.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 811.62M | -9.45% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.30B |
| Cereno Scientific AB | 1.98B |
| EQL Pharma AB | 1.71B |
| Orexo AB | 990.58M |
| Nanexa AB | 655.87M |
| Dicot Pharma AB | 599.79M |
| Moberg Pharma AB | 486.46M |
| Enzymatica AB | 475.76M |